Sensus Healthcare Net Income Over Time
| SRTS Stock | USD 5.11 0.02 0.39% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Sensus Healthcare Performance and Sensus Healthcare Correlation. Is there potential for Health Care Equipment & Supplies market expansion? Will Sensus introduce new products? Factors like these will boost the valuation of Sensus Healthcare. If investors know Sensus will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Sensus Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 4.333 | Earnings Share (0.18) | Revenue Per Share | Quarterly Revenue Growth 1.557 | Return On Assets |
The market value of Sensus Healthcare is measured differently than its book value, which is the value of Sensus that is recorded on the company's balance sheet. Investors also form their own opinion of Sensus Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Sensus Healthcare's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Sensus Healthcare's market value can be influenced by many factors that don't directly affect Sensus Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sensus Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sensus Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Sensus Healthcare's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Cross Equities Net Income Analysis
Compare Sensus Healthcare and related stocks such as Tela Bio, Icecure Medical, and Spectral AI Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TELA | (21.3 M) | (21.3 M) | (21.3 M) | (21.3 M) | (21.3 M) | (21.3 M) | (21.3 M) | (21.3 M) | (21.1 M) | (22.4 M) | (28.8 M) | (33.3 M) | (44.3 M) | (46.7 M) | (37.8 M) | (34.1 M) | (35.8 M) |
| ICCM | (4.6 M) | (4.6 M) | (4.6 M) | (4.6 M) | (4.7 M) | (3.8 M) | (3.3 M) | (2.9 M) | (3.5 M) | (4.8 M) | (4.8 M) | (10.1 M) | (17.2 M) | (14.7 M) | (15.3 M) | (13.8 M) | (13.1 M) |
| MDAI | (4 M) | (4 M) | (4 M) | (4 M) | (4 M) | (4 M) | (4 M) | (4 M) | (4 M) | (4 M) | (4 M) | (4 M) | (2.9 M) | (20.9 M) | (15.3 M) | (13.8 M) | (14.5 M) |
| CTSO | (80 K) | (5.5 M) | (3.7 M) | (4.7 M) | (9.3 M) | (8.1 M) | (11.9 M) | (8.5 M) | (17.2 M) | (19.3 M) | (7.8 M) | (24.6 M) | (32.8 M) | (29.2 M) | (20.7 M) | (18.6 M) | (17.7 M) |
| BDMD | (7.2 M) | (7.2 M) | (7.2 M) | (7.2 M) | (7.2 M) | (7.2 M) | (7.2 M) | (7.2 M) | (7.2 M) | (7.2 M) | 7.1 M | 11.7 M | 12.6 M | 10.5 M | 12.5 M | 14.3 M | 8.6 M |
| PETS | (1.8 M) | 16.7 M | 17.2 M | 18 M | 17.5 M | 20.6 M | 23.8 M | 37.3 M | 37.7 M | 25.9 M | 23.9 M | 21.1 M | 5.1 M | (7.5 M) | (7.5 M) | (8.6 M) | (8.2 M) |
| KPTI | (10.3 M) | (10.3 M) | (15.9 M) | (33.9 M) | (75.8 M) | (118.2 M) | (109.6 M) | (129 M) | (178.4 M) | (199.6 M) | (196.3 M) | (124.1 M) | (165.3 M) | (143.1 M) | (76.4 M) | (68.8 M) | (72.2 M) |
| IPSC | (244.8 M) | (244.8 M) | (244.8 M) | (244.8 M) | (244.8 M) | (244.8 M) | (244.8 M) | (244.8 M) | (244.8 M) | (244.8 M) | (53.6 M) | (95.8 M) | (130.9 M) | (136.7 M) | (126.6 M) | (145.6 M) | (152.8 M) |
| SNTI | (21.2 M) | (21.2 M) | (21.2 M) | (21.2 M) | (21.2 M) | (21.2 M) | (21.2 M) | (21.2 M) | (21.2 M) | (21.2 M) | (19.9 M) | (55.3 M) | (45.8 M) | (71.1 M) | (52.8 M) | (47.5 M) | (49.9 M) |
Sensus Healthcare and related stocks such as Tela Bio, Icecure Medical, and Spectral AI Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Sensus Healthcare financial statement analysis. It represents the amount of money remaining after all of Sensus Healthcare operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.My Equities
My Current Equities and Potential Positions
| Sensus Healthcare | SRTS |
Specialization | Health Care, Health Care Equipment & Services |
| Business Address | 851 Broken Sound |
| Exchange | NASDAQ Exchange |
USD 5.11
Additional Tools for Sensus Stock Analysis
When running Sensus Healthcare's price analysis, check to measure Sensus Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sensus Healthcare is operating at the current time. Most of Sensus Healthcare's value examination focuses on studying past and present price action to predict the probability of Sensus Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sensus Healthcare's price. Additionally, you may evaluate how the addition of Sensus Healthcare to your portfolios can decrease your overall portfolio volatility.